BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8463133)

  • 1. Infrequent ras mutation in human stomach cancers.
    Koshiba M; Ogawa O; Habuchi T; Hamazaki S; Shimada T; Takahashi R; Sugiyama T
    Jpn J Cancer Res; 1993 Feb; 84(2):163-7. PubMed ID: 8463133
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Point mutation of c-Ki-ras oncogene in gastric adenoma and adenocarcinoma with tubular differentiation.
    Kihana T; Tsuda H; Hirota T; Shimosato Y; Sakamoto H; Terada M; Hirohashi S
    Jpn J Cancer Res; 1991 Mar; 82(3):308-14. PubMed ID: 1902452
    [TBL] [Abstract][Full Text] [Related]  

  • 3. K-ras activation in gastric epithelial tumors in Japanese.
    Miki H; Ohmori M; Perantoni AO; Enomoto T
    Cancer Lett; 1991 Jun; 58(1-2):107-13. PubMed ID: 2049776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infrequent point mutations of ras oncogenes in gastric cancers.
    Nanus DM; Kelsen DP; Mentle IR; Altorki N; Albino AP
    Gastroenterology; 1990 Apr; 98(4):955-60. PubMed ID: 2179035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
    Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
    J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras oncogene activation in adenocarcinoma of the human pancreas. A study of 82 carcinomas using a combination of mutant-enriched polymerase chain reaction analysis and allele-specific oligonucleotide hybridization.
    Hruban RH; van Mansfeld AD; Offerhaus GJ; van Weering DH; Allison DC; Goodman SN; Kensler TW; Bose KK; Cameron JL; Bos JL
    Am J Pathol; 1993 Aug; 143(2):545-54. PubMed ID: 8342602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of c-Ki-ras oncogene mutation in gastric adenomas with formalin-fixed, paraffin-embedded biopsy materials.
    Tsuchiya C; Ohshima S; Takahama M
    J Gastroenterol; 1997 Feb; 32(1):28-33. PubMed ID: 9058292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of ras oncogene in gastric adenocarcinoma: association with histological phenotype.
    Kim TY; Bang YJ; Kim WS; Kang SH; Lee KU; Choe KJ; Kim NK
    Anticancer Res; 1997; 17(2B):1335-9. PubMed ID: 9137494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic significance of the K-ras gene codon 12 point mutation in stomach cancer. An analysis of 140 cases.
    Lee KH; Lee JS; Suh C; Kim SW; Kim SB; Lee JH; Lee MS; Park MY; Sun HS; Kim SH
    Cancer; 1995 Jun; 75(12):2794-801. PubMed ID: 7773929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric adenoma-carcinoma sequence with special reference to p53 and Ki-ras gene alterations.
    Sakurai S; Sano T; Maeshima A; Kashiwabara K; Oyama T; Fukuda T; Nakajima T
    Virchows Arch; 1995; 427(2):119-24. PubMed ID: 7582240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Point mutations of ras oncogenes are an early event in thyroid tumorigenesis.
    Namba H; Rubin SA; Fagin JA
    Mol Endocrinol; 1990 Oct; 4(10):1474-9. PubMed ID: 2283998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ras-family gene mutations in neoplasia of the ampulla of Vater.
    Scarpa A; Zamboni G; Achille A; Capelli P; Bogina G; Iacono C; Serio G; Accolla RS
    Int J Cancer; 1994 Oct; 59(1):39-42. PubMed ID: 7927901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycine to aspartic acid mutations at codon 13 of the c-Ki-ras gene in human gastrointestinal cancers.
    Nagata Y; Abe M; Kobayashi K; Yoshida K; Ishibashi T; Naoe T; Nakayama E; Shiku H
    Cancer Res; 1990 Feb; 50(3):480-2. PubMed ID: 2404571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation at codon 13 of the N-ras oncogene in a human stomach cancer.
    Nishida J; Kobayashi Y; Hirai H; Takaku F
    Biochem Biophys Res Commun; 1987 Jul; 146(1):247-52. PubMed ID: 3038106
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific Ki-ras codon 61 mutations may determine the development of urethan-induced mouse lung adenomas or adenocarcinomas.
    Nuzum EO; Malkinson AM; Beer DG
    Mol Carcinog; 1990; 3(5):287-95. PubMed ID: 2244961
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Demonstration of ras and p53 gene mutations in carcinomas in the forestomach and intestine and soft tissue sarcomas induced by N-methyl-N-nitrosourea in the rat.
    Matsumoto K; Iwase T; Hirono I; Nishida Y; Iwahori Y; Hori T; Asamoto M; Takasuka N; Kim DJ; Ushijima T; Nagao M; Tsuda H
    Jpn J Cancer Res; 1997 Feb; 88(2):129-36. PubMed ID: 9119740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infrequent K-ras activation in superficial-type (flat) colorectal adenomas and adenocarcinomas.
    Minamoto T; Sawaguchi K; Mai M; Yamashita N; Sugimura T; Esumi H
    Cancer Res; 1994 Jun; 54(11):2841-4. PubMed ID: 8187064
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of c-K-ras mutations in human gastrointestinal tumors.
    Arber N; Shapira I; Ratan J; Stern B; Hibshoosh H; Moshkowitz M; Gammon M; Fabian I; Halpern Z
    Gastroenterology; 2000 Jun; 118(6):1045-50. PubMed ID: 10833479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic alterations in gastric adenomas of intestinal and foveolar phenotypes.
    Abraham SC; Park SJ; Lee JH; Mugartegui L; Wu TT
    Mod Pathol; 2003 Aug; 16(8):786-95. PubMed ID: 12920223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Detection of G-->T mutation at codon 12 of H-ras oncogenes in gastric cancers with polymerase chain reaction and oligodeoxynucleotide(PCR-ODN)].
    Liu XF
    Zhonghua Bing Li Xue Za Zhi; 1992 Dec; 21(6):364-7. PubMed ID: 1299531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.